《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2016年 > 4期

分泌型卷曲相关蛋白5与肥胖及相关代谢性疾病的研究进展

来自:中国糖尿病杂志  编辑:朱云霞 钟远|点击数:|2016-04-25

【提要】 分泌型卷曲相关蛋白5(SFRP5)是新发现的脂肪因子,可通过抗炎机制改善IR。对肥胖和T2DM患者进行药物或生活方式干预可提高血循环SFRP5水平,改善IS。 SFRP5或可成为肥胖和T2DM新的治疗靶点。

【关键词】 分泌型卷曲相关蛋白5;脂肪因子;胰岛素抵抗;代谢性疾病

 

The progression of the research on SFRP5 and obesity and related metabolic diseases      ZHU Yun-xia, ZHONG Yuan, Department of Geriatrics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China

Corresponding author: ZHONG Yuan, E-mailzhyy_666@163.com

【Summary】 Secreted frizzled-related protein 5 is a novel adipokine, which has been shown to improve insulin resistance by inhibiting inflammation. Anti-diabetes drugs and lifestyle interventions have been reported to improve insulin resistance and increase circulating SFRP5 level in subjects with type 2 diabetes (T2DM) and obesity. SFRP5 may become the new therapeutic target.

【Key words】Secreted frizzled-related protein 5; Adipokine; Insulin resistance; Metabolic diseases

上一篇:Irisin与运动减肥的研究进展 下一篇:以严重糖尿病酮症酸中毒为初发表现的年轻超重/肥胖2型糖尿病4例报道及文献复习

相关阅读

    暂时没有相关文章